Authors: Shoombuatong, Watshara
Schaduangrat, Nalini
Nantasenamat, Chanin
Title: Towards understanding aromatase inhibitory activity via QSAR modeling
Language (ISO): en
Abstract: Aromatase is a rate-limiting enzyme for estrogen biosynthesis that is overproduced in breast cancer tissue. To block the growth of breast tumors, aromatase inhibitors (AIs) are employed to bind and inhibit aromatase in order to lower the amount of estrogen produced in the body. Although a number of synthetic aromatase inhibitors have been released for clinical use in the treatment of hormone-receptor positive breast cancer, these inhibitors may lead to undesirable side effects (e.g. increased rash, diarrhea and vomiting; effects on the bone, brain and heart) and therefore, the search for novel AIs continues. Over the past decades, there has been an intense effort in employing medicinal chemistry and quantitative structure-activity relationship (QSAR) to shed light on the mechanistic basis of aromatase inhibition. To the best of our knowledge, this article constitutes the first comprehensive review of all QSAR studies of both steroidal and non-steroidal AIs that have been published in the field. Herein, we summarize the experimental setup of these studies as well as summarizing the key features that are pertinent for robust aromatase inhibition.
Subject Headings: Aromatase
Aromatase inhibitors
Breast cancer
Structure-activity relationship
Data mining
Issue Date: 2018-07-20
Appears in Collections:Review Articles

Files in This Item:
File Description SizeFormat 
Nantasenamat_20072018_proof.pdfDNB487.9 kBAdobe PDFView/Open

This item is protected by original copyright

Items in Eldorado are protected by copyright, with all rights reserved, unless otherwise indicated.